Success Story: Medicine Researcher from Pakistan Secures I-140 NIW Approval Without RFE

Client’s Testimonial:

 

"Trust Chen Immigration’s customized template!"

 


 

On August 7th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Attending Physician in the Field of Medicine (Approval Notice).

 


 

General Field: Medicine

 

Position at the Time of Case Filing: Attending Physician

 

Country of Origin: Pakistan

 

State of Residence at the Time of Filing: Pennsylvania

 

Approval Notice Date: August 7th, 2026

 

Processing Time: 14 months, 30 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

Dhanasar-Based Petition Strategy

 

North America Immigration Law Group is pleased to share the approval of an I-140 NIW petition for a medicine researcher from Pakistan. Prepared under the Dhanasar framework, the petition demonstrated the substantial merit and national importance of the proposed endeavor, the client’s strong positioning to advance it, and the benefit of waiving the job offer and labor certification requirements. At the time of filing, the client was a practicing physician in the US working as an interventional cardiologist at a U.S. physician practice and held an MBBS.

 

Proposed Endeavor and National Importance

 

The client’s proposed endeavor focused on improving the detection, understanding, and treatment of cardiovascular diseases, including conditions that contribute to heart failure. The petition explained that this work supports better diagnosis, more effective and individualized treatment approaches, reduced risk of complications and hospitalizations, and improved overall health outcomes for patients with heart and related conditions in the United States.

 

Objective Evidence of Expertise

 

To show that the client was well positioned to advance the endeavor, the petition presented objective evidence of scholarly productivity and independent reliance. The client’s record included 43 peer-reviewed journal articles, including 18 first-authored or co-first-authored articles, 21 abstracts, including 10 first-authored abstracts, and 215 citations to the client’s published work, along with media coverage of the client’s research on genotype-guided cardiovascular treatment.

 

Demonstrating the Client’s Significance

 

The petition showed that the client’s significance extended beyond publication numbers. We demonstrated that independent researchers had relied on the client’s work in studies involving personalized prognosis in hematologic and cardiovascular conditions, risk assessment models, clinical screening approaches, and treatment optimization strategies in cardiovascular care.

 

The petition also contextualized the citation record by showing that 1 paper ranked among the top 1% and 1 paper ranked among the top 10% most-cited Clinical Medicine articles for their publication years. This helped demonstrate that the client’s research had received meaningful attention within the field.

 

NIW Approval and Outlook

 

The petition connected the client’s prior research record to the proposed cardiovascular medicine endeavor by emphasizing the client’s clinical expertise, publication record, citation impact, media recognition, and future research plans. USCIS approved the I-140 NIW petition without an RFE after a premium processing upgrade was requested.

 

We congratulate the client on this I-140 NIW approval and look forward to the client’s continued contributions to cardiovascular medicine, early disease detection, targeted treatment, and improved patient outcomes in the United States.